Haemonetics Reports Fourth Quarter Earnings for Fiscal Year 2026

Haemonetics (HAE) reported Q4 fiscal year 2026 earnings with total revenue of $346 million, a 5% increase. Adjusted EPS rose to $1.29 in the quarter and $4.96 for the full-year, reflecting strong performance despite margin pressures.

By Motley Fool Transcribing · Motley Fool · May 8, 2026, 15:20 UTC

Haemonetics Reports Fourth Quarter Earnings for Fiscal Year 2026

Tickers: $HAE

Topics: adjusted_eps capital_deployment free_cash_flow revenue

Read the full article at Motley Fool

More World news

Joe Lavis Named to D CEO's 2027 Dallas 500 List PR Newswire · November 12, 2026, 16:26 UTC
Sanmina Corporation (SANM) Shares Rise 8% Amid Five-Day Winning Streak Seeking Alpha · November 12, 2026, 16:23 UTC
Nvidia CEO Jensen Huang Resigns Amid Personal Scandal and National Security Concerns Motley Fool · November 12, 2026, 16:17 UTC
Citigroup Lowers Nvidia Price Target Following Jensen Huang's Departure Motley Fool · November 12, 2026, 16:19 UTC
The General Insurance and WWE Partner with Second Harvest Food Bank to Combat Food Insecurity in Nashville PR Newswire · November 12, 2026, 16:21 UTC
Fennec Pharmaceuticals Reports Record Q3 2026 Results with Significant EBITDA Growth Motley Fool · November 12, 2026, 16:11 UTC
Rockwell Medical Reports Q3 2026 Results and Announces Vantive Limited Acquisition Motley Fool · November 12, 2026, 16:11 UTC
BioHarvest Sciences Reports Q3 2026 Financial Results Amid Strategic Shift to Fragrance Development Motley Fool · November 12, 2026, 16:11 UTC
Xunlei Reports Q3 2026 Revenue Growth Amid Increased Operating Losses and Investment Adjustments Motley Fool · November 12, 2026, 16:11 UTC
Sandisk Shares Decline Following Resignation of Nvidia CEO Jensen Huang Motley Fool · November 12, 2026, 16:14 UTC